Politicization has its costs. That’s the lesson being learned by the Biden administration today as two high-level FDA officials, both involved in the approval and distribution of the vaccines, have announced they are leaving their jobs due to meddling by the White House.
According to Endpoints News, Marion Gruber and Phil Krause, the Director and Deputy Director of the FDA’s Office of Vaccine Research and Review, will be leaving in October and November respectively.
Marion Gruber, director of the FDA’s Office of Vaccines Research & Review and 32-year veteran of the agency, will leave at the end of October, and OVRR deputy director Phil Krause, who’s been at FDA for more than a decade, will leave in November.
But it’s the reason why they are exiting that has people questioning just how far gone other agencies like the CDC are in regards to their open shilling for the administration while forgoing a normal, scientific approach. According to the report, it was the decision by the White House to ignore the FDA and announce COVID vaccine booster shots that was the last straw here.
A former senior FDA leader told Endpoints that they’re departing because they’re frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA. The former FDAer also said he’s heard they’re upset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots.
Keep Reading on Red State…
